Precision Autoimmune Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $20.9M

  • Investors
  • 3

Precision Autoimmune Therapeutics General Information

Description

Developer of innovative drugs intended to treat autoimmune diseases. The company develops cell therapy and innovative drugs for precision treatment of autoimmune and inflammatory diseases, enabling patients to get better treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Floor 1-101-31, Building 2, Yard 1, Jiuqiao Road
  • Beijing Economic and Technological Development Zone
  • Beijing
  • China
Primary Industry
Drug Discovery
Corporate Office
  • Floor 1-101-31, Building 2, Yard 1, Jiuqiao Road
  • Beijing Economic and Technological Development Zone
  • Beijing
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Precision Autoimmune Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 05-Jul-2022 $20.9M Completed Pre-Clinical Trials
To view Precision Autoimmune Therapeutics’s complete valuation and funding history, request access »

Precision Autoimmune Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
CASI Pharmaceuticals Corporation Minority
Emerging Technology Partners (Venture Capital) Venture Capital Minority
Redhill Capital Growth/Expansion Minority
To view Precision Autoimmune Therapeutics’s complete investors history, request access »

Precision Autoimmune Therapeutics FAQs

  • When was Precision Autoimmune Therapeutics founded?

    Precision Autoimmune Therapeutics was founded in 2022.

  • Where is Precision Autoimmune Therapeutics headquartered?

    Precision Autoimmune Therapeutics is headquartered in Beijing, China.

  • What industry is Precision Autoimmune Therapeutics in?

    Precision Autoimmune Therapeutics’s primary industry is Drug Discovery.

  • Is Precision Autoimmune Therapeutics a private or public company?

    Precision Autoimmune Therapeutics is a Private company.

  • What is Precision Autoimmune Therapeutics’s current revenue?

    The current revenue for Precision Autoimmune Therapeutics is .

  • How much funding has Precision Autoimmune Therapeutics raised over time?

    Precision Autoimmune Therapeutics has raised $20.9M.

  • Who are Precision Autoimmune Therapeutics’s investors?

    CASI Pharmaceuticals, Emerging Technology Partners (Venture Capital), and Redhill Capital have invested in Precision Autoimmune Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process